AEGISAEGISConsumer Alert & Verification
Official alertHighwp_page_registry

Amedin 5mg and 10mg

Published Sep 18, 2024Source

What we know

Summary Date Recall was issued:Product Name:Manufacturer:Recalling Firm:Batch(es):Manufacturing Date:Expiry Date:Reason for Recall: 6th September 2023Amedin 5mg and 10mgE.P DIS CFAO HealthcareGokals LaborexB20554March 2023February 2024This recall has been necessitated as a result of ongoing stability analysis by the manufacturer which confirms that the related substance test carried out on the product is out of specification. This makes the product substandard and therefore not recommended for its intended use. AnnouncementThis recall is necessitated as a result of warehouse market surveillance conducted at the warehouse. Actual product specification is a powder for oral suspension. The affected batches were caked and not free flowing. This makes the product substandard and therefore not recommended for its intended use.

Safety advice

  • Stop using or purchasing the product if the notice asks you to.
  • Keep receipts, batch numbers and packaging — they help with returns or investigations.
  • Share this alert with anyone who might be affected, especially relatives and colleagues.
  • If you believe you’ve been harmed, contact the official source or a relevant authority.

Related advisories